{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:19:01Z","timestamp":1775881141479,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["824747"],"award-info":[{"award-number":["824747"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"crossref","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"crossref","award":["825747"],"award-info":[{"award-number":["825747"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Int Health Hum Rights"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cervical cancer claims 311,000 lives annually, and 90% of these deaths occur in low- and middle-income countries. Cervical cancer is a highly preventable and treatable disease, if detected through screening at an early stage. Governments have a responsibility to screen women for precancerous cervical lesions. Yet, national screening programmes overlook many poor women and those marginalised in society. Under-screened women (called hard-to-reach) experience a higher incidence of cervical cancer and elevated mortality rates compared to regularly-screened women. Such inequalities deprive hard-to-reach women of the full enjoyment of their right to sexual and reproductive health, as laid out in Article 12 of the International Covenant on Economic, Social and Cultural Rights and General Comment No. 22.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>This article argues first for tailored and innovative national cervical cancer screening programmes (NCSP) grounded in human rights law, to close the disparity between women who are afforded screening and those who are not. Second, acknowledging socioeconomic disparities requires governments to adopt and refine universal cancer control through NCSPs aligned with human rights duties, including to reach all eligible women. Commonly reported- and chronically under-addressed- screening disparities relate to the <jats:italic>availability<\/jats:italic> of sufficient health facilities and human resources (example from Kenya), the <jats:italic>physical accessibility<\/jats:italic> of health services for rural and remote populations (example from Brazil), and the <jats:italic>accessibility of information<\/jats:italic> sensitive to cultural, ethnic, and linguistic barriers (example from Ecuador). Third, governments can adopt new technologies to overcome individual and structural barriers to cervical cancer screening. National cervical cancer screening programmes should tailor screening methods to under-screened women, bearing in mind that eliminating systemic discrimination may require committing greater resources to traditionally neglected groups.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Governments have human rights obligations to refocus screening policies and programmes on women who are disproportionately affected by discrimination that impairs their full enjoyment of the right to sexual and reproductive health. National cervical cancer screening programmes that keep the right to health principles (above) central will be able to expand screening among low-income, isolated and other marginalised populations, but also women in general, who, for a variety of reasons, do not visit healthcare providers for regular screenings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12914-020-00237-9","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T10:03:45Z","timestamp":1596189825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3958-0244","authenticated-orcid":false,"given":"Katrina","family":"Perehudoff","sequence":"first","affiliation":[]},{"given":"Heleen","family":"Vermandere","sequence":"additional","affiliation":[]},{"given":"Alex","family":"Williams","sequence":"additional","affiliation":[]},{"given":"Sergio","family":"Bautista-Arredondo","sequence":"additional","affiliation":[]},{"given":"Elien","family":"De Paepe","sequence":"additional","affiliation":[]},{"given":"Sonia","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Gama","sequence":"additional","affiliation":[]},{"given":"Ines","family":"Keygnaert","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Jose","family":"Ortiz","sequence":"additional","affiliation":[]},{"given":"Elizaveta","family":"Padalko","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Nathalie","family":"Vanderheijden","sequence":"additional","affiliation":[]},{"given":"Bernardo","family":"Vega","sequence":"additional","affiliation":[]},{"given":"Bo","family":"Verberckmoes","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Degomme","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"237_CR1","doi-asserted-by":"publisher","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136. https:\/\/doi.org\/10.1002\/ijc.29210.","DOI":"10.1002\/ijc.29210"},{"key":"237_CR2","volume-title":"Cervical Cancer: An NCD We Can Overcome. At: Intercontinental Hotel, Geneva","author":"DTA Ghebreyesus","year":"2018","unstructured":"Dr Tedros Adhanom Ghebreyesus, WHO Director-General. Cervical Cancer: An NCD We Can Overcome. At: Intercontinental Hotel, Geneva 2018. https:\/\/www.who.int\/reproductivehealth\/DG_Call-to-Action.pdf."},{"key":"237_CR3","unstructured":"World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013\u20132020. Geneva: World Health Organization; 2013. http:\/\/www.who.int\/iris\/handle\/10665\/94384."},{"key":"237_CR4","unstructured":"General comment no. 22 on the Right to sexual and reproductive health (article 12 of the International Covenant on Economic, Social and Cultural Rights). E\/C.12\/GC\/22.UN. Committee on Economic, Social and Cultural Rights; 2016. http:\/\/docstore.ohchr.org\/SelfServices\/FilesHandler.ashx?enc=4slQ6QSmlBEDzFEovLCuW1a0Szab0oXTdImnsJZZVQfQejF41Tob4CvIjeTiAP6sGFQktiae1vlbbOAekmaOwDOWsUe7N8TLm%2BP3HJPzxjHySkUoHMavD%2Fpyfcp3Ylzg."},{"key":"237_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/cncr.29813","volume":"122","author":"BL Bychkovsky","year":"2015","unstructured":"Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, Lopes GDL, Dizon DS, et al. Cervical cancer control in Latin America: a call to action. Cancer. 2015;122:502\u201314. https:\/\/doi.org\/10.1002\/cncr.29813.","journal-title":"Cancer"},{"key":"237_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ijc.11141","volume":"105","author":"S Parikh","year":"2013","unstructured":"Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2013;105:687\u201391. https:\/\/doi.org\/10.1002\/ijc.11141.","journal-title":"Int J Cancer"},{"issue":"4","key":"237_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/17441692.2017.1405457","volume":"14","author":"L Forman","year":"2019","unstructured":"Forman L. What do human rights bring to discussions of power and politics in health policy and systems? Global Public Health. 2019;14(4):489\u2013502.","journal-title":"Global Public Health"},{"key":"237_CR8","volume-title":"Model List of Essential Medicines","author":"WHO","year":"2019","unstructured":"WHO. In: The World Health Organization, editor. Model List of Essential Medicines. 21st ed; 2019. Available at https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325771\/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1 [Accessed 1 Nov 2019].","edition":"21"},{"key":"237_CR9","unstructured":"WHO. Model List of Essential In Vitro Diagnostics. 1st ed: The World Health Organization; 2018. Available at https:\/\/www.who.int\/medical_devices\/diagnostics\/WHO_EDL_2018.pdf [Accessed 27 Feb 2019]."},{"issue":"3","key":"237_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijgo.2016.03.011","volume":"134","author":"B Olson","year":"2016","unstructured":"Olson B, Gribble B, Dias J, Curryer C, Vo K, Kowal P, Byles J. Cervical cancer screening programs and guidelines in low-and middle-income countries. Int J Gynecol Obstet. 2016;134(3):239\u201346.","journal-title":"Int J Gynecol Obstet"},{"key":"237_CR11","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.vaccine.2006.05.121","volume":"24","author":"L Denny","year":"2006","unstructured":"Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006;24:S71\u20137.","journal-title":"Vaccine"},{"key":"237_CR12","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","volume":"45","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45:2640\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2009.07.018.","journal-title":"Eur J Cancer"},{"key":"237_CR13","doi-asserted-by":"publisher","unstructured":"Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jer\u00f3nimo J, et al. Cervical Cancer screening programs in Latin America and the Caribbean. Vaccine. 2008;26. https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.013.","DOI":"10.1016\/j.vaccine.2008.06.013"},{"key":"237_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ypmed.2017.11.019","volume":"111","author":"I Rees","year":"2018","unstructured":"Rees I, Jones D, Chen H, Macleod U. Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: a systematic review. Prev Med. 2018;111:323\u201335.","journal-title":"Prev Med"},{"key":"237_CR15","unstructured":"Ministry of Health, Kenya. National Cancer Control Strategy 2017\u20132022, pg. 53. Nairobi: Ministry of Health, Kenya; 2017."},{"issue":"1","key":"237_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12885-018-4642-9","volume":"18","author":"M Gatumo","year":"2018","unstructured":"Gatumo M, Gacheri S, Sayed AR, Scheibe A. Women\u2019s knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: a cross-sectional study. BMC Cancer. 2018;18(1):745.","journal-title":"BMC Cancer"},{"key":"237_CR17","volume-title":"Cancer Country Profiles, Kenya","author":"World Health Organization","year":"2014","unstructured":"World Health Organization Cancer Country Profiles, Kenya; 2014. Available at https:\/\/www.who.int\/cancer\/country-profiles\/ken_en.pdf [Accessed 27 Feb 2019]."},{"key":"237_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1590\/s0102-311x2013000800019","volume":"29","author":"KC Mascarello","year":"2013","unstructured":"Mascarello KC, Zandonade E, Amorim MHC. Survival analysis of women with cervical cancer treated at a referral hospital for oncology in Esp\u00edrito Santo state, Brazil, 2000-2005. Cadernos De Sa\u00fade P\u00fablica. 2013;29:823\u201331. https:\/\/doi.org\/10.1590\/s0102-311x2013000800019.","journal-title":"Cadernos De Sa\u00fade P\u00fablica"},{"key":"237_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1590\/s0034-8910.2014048005214","volume":"48","author":"VR Girianelli","year":"2014","unstructured":"Girianelli VR, Gamarra CJ, Silva GAE. Disparities in cervical and breast cancer mortality in Brazil. Rev Saude Publica. 2014;48:459\u201367. https:\/\/doi.org\/10.1590\/s0034-8910.2014048005214.","journal-title":"Rev Saude Publica"},{"key":"237_CR20","doi-asserted-by":"publisher","unstructured":"RFA C, Longatto-Filho A, Pinheiro C, Zeferino LC, Fregnani JH. Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A time for reflection. PLoS One. 2015:10. https:\/\/doi.org\/10.1371\/journal.pone.0138945.","DOI":"10.1371\/journal.pone.0138945"},{"key":"237_CR21","doi-asserted-by":"publisher","unstructured":"Filho AL, Silva TB, Rodrigues S, Haikel RL. Combined screening for breast and gynecological Cancers using Mobile clinics: the Barretos experience (Brazil). Breast Gynecological Cancers. 2013:189\u201399. https:\/\/doi.org\/10.1007\/978-1-4614-1876-4_10.","DOI":"10.1007\/978-1-4614-1876-4_10"},{"key":"237_CR22","volume-title":"ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Ecuador. Summary Report","author":"L Bruni","year":"2018","unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, Bosch FX, de Sanjos\u00e9 S. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Ecuador. Summary Report; 2018. [Accessed 27 Feb 2019]."},{"key":"237_CR23","volume-title":"Prevalencia de c\u00e1ncer de cuello uterino en el Ecuador y estrategias para su reducci\u00f3n. Repositorio Digital De La Universidad De Cuenca: Home","author":"V Crespo","year":"2012","unstructured":"Crespo V, Jos\u00e9 B, Coello S, Nube MCde la. Prevalencia de c\u00e1ncer de cuello uterino en el Ecuador y estrategias para su reducci\u00f3n. Repositorio Digital De La Universidad De Cuenca: Home 2012. http:\/\/dspace.ucuenca.edu.ec\/handle\/123456789\/20387."},{"key":"237_CR24","unstructured":"International Work Group for Indigenous Affairs (IWGIA). Indigenous peoples in Ecuador. [website] https:\/\/www.iwgia.org\/en\/ecuador, https:\/\/www.iwgia.org\/en\/ecuador.html."},{"key":"237_CR25","volume-title":"Percepciones sobre la salud sexual y reproductiva de las mujeres ind\u00edgenas Kichwas y Shuaras. Ecuador, 2016","author":"JI Ortiz Segarra","year":"2016","unstructured":"Ortiz Segarra JI et al. Percepciones sobre la salud sexual y reproductiva de las mujeres ind\u00edgenas Kichwas y Shuaras. Ecuador, 2016. 2016."},{"key":"237_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/1049732317742129","volume":"28","author":"P Nugus","year":"2018","unstructured":"Nugus P, D\u00e9salliers J, Morales J, Graves L, Evans A, Macaulay AC. Localizing global medicine: challenges and opportunities in cervical screening in an indigenous Community in Ecuador. Qual Health Res. 2018;28:800\u201312. https:\/\/doi.org\/10.1177\/1049732317742129.","journal-title":"Qual Health Res"},{"key":"237_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1590\/s0080-623420160000300010","volume":"50","author":"Y Godoy","year":"2016","unstructured":"Godoy Y, Godoy C, Reyes J. Social representations of gynecologic Cancer screening assessment a qualitative research on Ecuadorian women. Revista Da Escola De Enfermagem Da USP. 2016;50:68\u201373. https:\/\/doi.org\/10.1590\/s0080-623420160000300010.","journal-title":"Revista Da Escola De Enfermagem Da USP"},{"issue":"6","key":"237_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002325","volume":"14","author":"P Bloem","year":"2017","unstructured":"Bloem P, Ogbuanu I. Vaccination to prevent human papillomavirus infections: from promise to practice. PLoS Med. 2017 Jun 27;14(6):e1002325.","journal-title":"PLoS Med"},{"issue":"1","key":"237_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12889-015-1779-1","volume":"15","author":"D Riethmuller","year":"2015","unstructured":"Riethmuller D, Jacquard AC, St Guily JL, Aubin F, Carcopino X, Pradat P, Dahlab A, Pr\u00e9tet JL. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. BMC Public Health. 2015;15(1):453.","journal-title":"BMC Public Health"},{"key":"237_CR30","doi-asserted-by":"crossref","unstructured":"Abbas KM, Van Zandvoort K, Brisson M, Jit M. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study. Lancet Glob Health. 2020;8(4):e536\u201344.","DOI":"10.1016\/S2214-109X(20)30022-X"},{"issue":"3","key":"237_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ijgo.12075","volume":"136","author":"L Mariani","year":"2017","unstructured":"Mariani L, Preti M, Cristoforoni P, Stigliano CM, Perino A. Overview of the benefits and potential issues of the nonavalent HPV vaccine. Int J Gynecol Obstet. 2017 Mar;136(3):258\u201365.","journal-title":"Int J Gynecol Obstet"},{"issue":"7","key":"237_CR32","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","volume":"4","author":"L Bruni","year":"2016","unstructured":"Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjos\u00e9 S, Castellsagu\u00e9 X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016 Jul 1;4(7):e453\u201363.","journal-title":"Lancet Glob Health"},{"key":"237_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0002-9378(16)40621-6","volume":"42","author":"GN Papanicolaou","year":"1941","unstructured":"Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Presented before the New York obstetrical society, march 11, 1941. Am J Obstet Gynecol. 1941;42:193\u2013206. https:\/\/doi.org\/10.1016\/s0002-9378(16)40621-6.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"237_CR34","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","volume":"285","author":"MH Stoler","year":"2001","unstructured":"Stoler MH, Schiffman M. For the atypical squamous cells of undetermined significance\u2013low-grade squamous intraepithelial lesion triage study (ALTS) group. Interobserver reproducibility of cervical Cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA. 2001;285(11):1500\u20135. https:\/\/doi.org\/10.1001\/jama.285.11.1500.","journal-title":"JAMA"},{"issue":"5","key":"237_CR35","first-page":"1107","volume":"12","author":"JG Senapathy","year":"2011","unstructured":"Senapathy JG, Umadevi P, Kannika PS. The present scenario of cervical cancer control and HPV epidemiology in India: an outline. Asian Pac J Cancer Prev. 2011 Jan 1;12(5):1107\u201315.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"237_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijgo.2015.07.024","volume":"132","author":"RA Mustafa","year":"2016","unstructured":"Mustafa RA, Santesso N, Khatib R, Mustafa AA, Wiercioch W, Kehar R, Gandhi S, Chen Y, Cheung A, Hopkins J, Ma B. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. Int J Gynecol Obstet. 2016;132(3):259\u201365.","journal-title":"Int J Gynecol Obstet"},{"key":"237_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","volume":"1","author":"LV Karsa","year":"2015","unstructured":"Karsa LV, Arbyn M, Vuyst HD, Dillner J, Dillner L, Franceschi S, et al. European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Research. 2015;1:22\u201331. https:\/\/doi.org\/10.1016\/j.pvr.2015.06.006.","journal-title":"Papillomavirus Research"},{"key":"237_CR38","doi-asserted-by":"publisher","unstructured":"Benoy IH, Broeck DV, Ruymbeke MJ, Sahebali S, Arbyn M, Bogers JJ, et al. Prior knowledge of HPV status improves detection of CIN2 by cytology screening. Am J Obstet Gynecol. 2011;205. https:\/\/doi.org\/10.1016\/j.ajog.2011.06.101.","DOI":"10.1016\/j.ajog.2011.06.101"},{"key":"237_CR39","unstructured":"WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013."},{"key":"237_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2013.07.092","volume":"131","author":"AT Lorenzi","year":"2013","unstructured":"Lorenzi AT, Fregnani JHT, Possati-Resende JC, Neto CS, Villa LL, Longatto-Filho A. Self-collection for high-risk HPV detection in Brazilian women using the careHPV\u2122 test. Gynecol Oncol. 2013;131:131\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.092.","journal-title":"Gynecol Oncol"},{"key":"237_CR41","doi-asserted-by":"publisher","unstructured":"Katz LMC. Review of the Brazilian guidelines for cervical Cancer screening, 2016. Jornal Brasileiro De Patologia e Medicina Laboratorial. 2016;52. https:\/\/doi.org\/10.5935\/1676-2444.20160034.","DOI":"10.5935\/1676-2444.20160034"},{"key":"237_CR42","first-page":"127","volume":"23","author":"CK Yu","year":"1998","unstructured":"Yu CK, Rymer J. Women\u2019s attitudes to and awareness of smear testing and cervical cancer. Br J Fam Plann. 1998;23:127\u201333.","journal-title":"Br J Fam Plann"},{"key":"237_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijgo.2014.02.026","volume":"126","author":"AJ Rosenbaum","year":"2014","unstructured":"Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obstet. 2014;126:156\u201360. https:\/\/doi.org\/10.1016\/j.ijgo.2014.02.026.","journal-title":"Int J Gynecol Obstet"},{"key":"237_CR44","doi-asserted-by":"publisher","unstructured":"Sultana F, Mullins R, English DR, Simpson JA, Drennan KT, Heley S, et al. Women\u2019s experience with home-based self-sampling for human papillomavirus testing. BMC Cancer. 2015;15. https:\/\/doi.org\/10.1186\/s12885-015-1804-x.","DOI":"10.1186\/s12885-015-1804-x"},{"key":"237_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1071\/sh16077","volume":"14","author":"J Silva","year":"2017","unstructured":"Silva J, Cerqueira F, Medeiros R. Acceptability of self-sampling in Portuguese women: the good, the bad or the ugly? Sex Health. 2017;14:298. https:\/\/doi.org\/10.1071\/sh16077.","journal-title":"Sex Health"},{"issue":"4","key":"237_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/07399332.2014.959168","volume":"37","author":"M Maar","year":"2016","unstructured":"Maar M, Wakewich P, Wood B, Severini A, Little J, Burchell AN, Ogilvie G, Zehbe I. Strategies for increasing cervical Cancer screening amongst first nations communities in Northwest Ontario, Canada. Health Care Women Int. 2016;37(4):478\u201395. https:\/\/doi.org\/10.1080\/07399332.2014.959168.","journal-title":"Health Care Women Int"},{"key":"237_CR47","doi-asserted-by":"publisher","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human Papillomavirus testing in secondary prevention of cervical Cancer. Vaccine. 2012;30. https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.095.","DOI":"10.1016\/j.vaccine.2012.06.095"},{"key":"237_CR48","doi-asserted-by":"publisher","unstructured":"Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3. https:\/\/doi.org\/10.1016\/s2214-109x(14)70354-7.","DOI":"10.1016\/s2214-109x(14)70354-7"},{"key":"237_CR49","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1128\/jcm.01254-11","volume":"49","author":"JC Gage","year":"2011","unstructured":"Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, et al. Comparative performance of human Papillomavirus DNA testing using novel sample collection methods. J Clin Microbiol. 2011;49:4185\u20139. https:\/\/doi.org\/10.1128\/jcm.01254-11.","journal-title":"J Clin Microbiol"},{"key":"237_CR50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1067\/mob.2002.121076","volume":"186","author":"DM Harper","year":"2002","unstructured":"Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR\u2013determined human papillomavirus detection methods: self-sampling versus clinician-directed\u2013biologic concordance and women's preferences. Am J Obstet Gynecol. 2002;186:365\u201373. https:\/\/doi.org\/10.1067\/mob.2002.121076.","journal-title":"Am J Obstet Gynecol"},{"key":"237_CR51","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1067\/mob.2002.122390","volume":"186","author":"FR Lorenzato","year":"2002","unstructured":"Lorenzato FR, Singer A, Ho L, Santos LC, Batista RDL, Lubambo TM, et al. Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples. Am J Obstet Gynecol. 2002;186:962\u20138. https:\/\/doi.org\/10.1067\/mob.2002.122390.","journal-title":"Am J Obstet Gynecol"},{"key":"237_CR52","doi-asserted-by":"publisher","unstructured":"Zehbe I, Wakewich P, King A-D, Morrisseau K, Tuck C. Self-administered versus provider-directed sampling in the Anishinaabek cervical Cancer screening study (ACCSS): a qualitative investigation with Canadian first nations women. BMJ Open. 2017;7. https:\/\/doi.org\/10.1136\/bmjopen-2017-017384.","DOI":"10.1136\/bmjopen-2017-017384"},{"key":"237_CR53","doi-asserted-by":"publisher","unstructured":"Lippman SA, Jones HE, Luppi CG, Pinho AA, Veras MAMS, Janneke H, Van De Wijgert HM. Home-Based Self-Sampling and Self-Testing for Sexually Transmitted Infections: Acceptable and Feasible Alternatives to Provider-Based Screening in Low-Income Women in Sao Paulo, Brazil. Sex Transm Dis. 2006;PAP. https:\/\/doi.org\/10.1097\/01.olq.0000245958.3496.","DOI":"10.1097\/01.olq.0000245958.3496"},{"key":"237_CR54","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/1055-9965.epi-14-1417","volume":"24","author":"M Arbyn","year":"2015","unstructured":"Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical Cancer screening program. Cancer Epidemiol Biomark Prev. 2015;24:769\u201372. https:\/\/doi.org\/10.1158\/1055-9965.epi-14-1417.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"237_CR55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1055-9965.epi-14-0998","volume":"24","author":"K Rozemeijer","year":"2014","unstructured":"Rozemeijer K, de Kok IMCM, Naber SK, van Kemenade FJ, Penning C, van Rosmalen J, et al. Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits? Cancer Epidemiol Biomarkers Prev. 2014;24:773\u201382. https:\/\/doi.org\/10.1158\/1055-9965.epi-14-0998.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"237_CR56","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","volume":"31","author":"XW Jin","year":"2016","unstructured":"Jin XW, Lipold L, Foucher J, Sikon A, Brainard J, Belinson J, et al. Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical Cancer screening for women above age 30 years. J Gen Intern Med. 2016;31:1338\u201344. https:\/\/doi.org\/10.1007\/s11606-016-3772-5.","journal-title":"J Gen Intern Med"},{"key":"237_CR57","doi-asserted-by":"publisher","unstructured":"Lorenzi AT, Syrj\u00e4nen KJ, Longatto-Filho A. Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective. Virol J. 2015;12. https:\/\/doi.org\/10.1186\/s12985-015-0342-0.","DOI":"10.1186\/s12985-015-0342-0"},{"key":"237_CR58","unstructured":"World Health Organization. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 2010."}],"container-title":["BMC International Health and Human Rights"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12914-020-00237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12914-020-00237-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12914-020-00237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:25:49Z","timestamp":1627687549000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinthealthhumrights.biomedcentral.com\/articles\/10.1186\/s12914-020-00237-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1186\/s12914-020-00237-9","relation":{},"ISSN":["1472-698X"],"issn-type":[{"value":"1472-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}